Latest News and Press Releases

TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Casey House – a hospital unlike any other providing care to those living with and at risk of HIV – today announces the launch of its latest advocacy campaign,...

New York, July 12, 2023 (GLOBE NEWSWIRE) -- The global animal healthcare market size was valued at USD 39.01 billion in 2022 and is projected to reach USD 60.3 billion by 2033, growing at a CAGR of...

KNOXVILLE, TN, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has expanded its sponsored research program with Michio Kurosu, PhD, Professor, Department...

New York, July 13, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Anti-Infective Agents Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type,...

COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE AVOIR REÇU L'AUTORISATION DE REPRISE DES INCLUSIONS DE PATIENTS DANS SON ÉTUDE DE PHASE 2 DU MASITINIB DANS LA COVID-19, CE QUI SIGNIFIE LA REPRISE DU...

PRESS RELEASE AB SCIENCE ANNOUNCES THAT IT HAS RECEIVED AUTHORIZATION TO RESUME PATIENT ENROLLMENT IN ITS PHASE 2 COVID-19 STUDY OF MASITINIB, SIGNIFIYING RESUMPTION OF RECRUITMENT IN ALL THREE OF...

BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic,...

DELRAY BEACH, Fla., April 15, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development...

Patent allowed by the USPTO that includes claims for niclosamide as a treatment for COVID-19 GI infectionsCOVID-19 GI infections are a significant unmet clinical need; AzurRx estimates potential U.S....

Portland, OR, Oct. 22, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global anti-microbial coatings market generated $4.0 billion in 2019, and is...